HealthcareServices

Global Predictive Genetic Counselling Industry Insights: Key Trends and Growth Estimates

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the predictive genetic counselling market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Predictive Genetic Counselling Market from 2026 to 2030?

The predictive genetic counselling market has seen substantial expansion in its size over recent years. It is projected to grow from $4.19 billion in 2025 to $4.87 billion in 2026, reflecting a compound annual growth rate (CAGR) of 16.2%. The market’s historical growth can be attributed to several key factors, including the increasing utilization of family history evaluation, the expansion of cancer risk screening programs, a growing acceptance of genetic testing, improvements in counseling methodologies, and rising public awareness of inherited diseases.

The predictive genetic counselling market is projected to expand significantly in the coming years, reaching a size of $8.79 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.9%. This anticipated growth during the forecast period stems from factors such as the greater incorporation of genomics into standard healthcare practices, the increasing acceptance of virtual counseling platforms, the broadening of preventive screening programs, the expanding application of AI-based genetic interpretation, and a rising need for individualized health risk information. Key developments expected over the forecast horizon encompass a surge in demand for online genetic counseling, an uptick in the utilization of polygenic risk scoring, wider acceptance of direct-to-consumer genetic testing, the broadening scope of predictive oncology counseling, and a heightened emphasis on educating patients and supporting their decisions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27397&type=smp

What Drivers Are Affecting Demand In The Predictive Genetic Counselling Market?

The expanding presence of genetic disorders is anticipated to propel the future growth of the predictive genetic counselling market. These disorders are conditions stemming from alterations or defects in a person’s DNA, influencing the body’s growth, development, and overall function. The rise in genetic disorders can be attributed to increasing parental age, as conception at an older age is associated with a higher probability of genetic mutations in offspring. Genetic disorders contribute to the development of predictive genetic counselling by escalating the demand for risk assessment services that help individuals understand their likelihood of inheriting or passing on such conditions. For instance, in October 2024, data from the Cystic Fibrosis Trust, a UK-based charitable organization, indicated that the number of patients registered with cystic fibrosis rose to 11,318 in 2023, an increase from 11,148 in 2022. Thus, the increasing occurrence of genetic disorders is a key driver for the predictive genetic counselling market.

Which Segment Groups Are Influencing The Predictive Genetic Counselling Market?

The predictive genetic counselling market covered in this report is segmented –

1) By Service Type: Risk Assessment, Carrier Testing, Predictive Testing, Other Service Types

2) By Mode Of Delivery: In-Person, Online

3) By Application: Consumer Genomics, Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users

Subsegments:

1) By Risk Assessment: Family History Evaluation, Lifestyle And Environmental Risk Analysis, Polygenic Risk Score Analysis, Hereditary Disease Susceptibility Screening

2) By Carrier Testing: Cystic Fibrosis Carrier Testing, Tay-Sachs Carrier Testing, Fragile X Syndrome Testing, Sickle Cell Carrier Testing, Thalassemia Carrier Screening

3) By Predictive Testing: Breast Cancer Gene 1 (BRCA1) Or Breast Cancer Gene 2 (BRCA2) Mutation Testing, Lynch Syndrome Testing, Huntington’s Disease Testing, Cardiovascular Genetic Risk Testing, Neurological Disorder Prediction Testing

4) By Other Service Types: Pharmacogenomic Testing, Prenatal Genetic Testing, Newborn Genetic Screening, Direct-To-Consumer Genetic Testing, Whole Genome Sequencing For Prediction

What Trends Are Projected To Support The Growth Of The Predictive Genetic Counselling Market?

Leading companies in the predictive genetic counselling market are concentrating on developing advanced solutions, such as the predictive genetic testing service, for early disease risk detection and to support informed clinical decision-making. A predictive genetic testing service refers to a medical offering that analyzes an individual’s DNA to identify genetic variations linked to an elevated risk of developing specific inherited conditions or diseases in the future. For instance, in August 2024, Genetic Technologies Limited, an Australia-based company providing genomics-based health testing, launched the geneType Risk Assessment test. This test serves as a unique, comprehensive, multi-risk predictive genetic screening tool designed to evaluate an individual’s probability of developing serious conditions like breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease, and type 2 diabetes. It combines clinically validated polygenic risk scores with non-genetic factors such as age, family history, and clinical measurements to deliver a personalized, actionable risk profile. Designed for proactive health management, it also provides clear reports with tailored recommendations to guide preventive care and lifestyle choices in over 42 countries.

Who Are The Major Companies Operating In The Predictive Genetic Counselling Market?

Major companies operating in the predictive genetic counselling market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Natera Inc, Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, 23andMe Holding Co, Color Genomics Inc, deCODE genetics, Centogene NV, Admera Health LLC, Mapmygenome, Exact Sciences Corporation, BGI Group

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/predictive-genetic-counselling-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Predictive Genetic Counselling Market?

North America was the largest region in the predictive genetic counselling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic counselling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Predictive Genetic Counselling Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27397&type=smp

Browse Through More Reports Similar to the Global Predictive Genetic Counselling Market 2026, By The Business Research Company

Commercial Property Insurance Market Report 2026

https://www.thebusinessresearchcompany.com/report/commercial-property-insurance-global-market-report

Property Management Software Market 2026

https://www.thebusinessresearchcompany.com/report/property-management-software-market

Property Management Service Market Report 2026

https://www.thebusinessresearchcompany.com/report/property-management-service-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795